Methylene blue (English Wikipedia)

"Methylene Blue". 3 Little Fish Sdn Bhd. Kelana Jaya, Selangor, Malaysia. 10 September 2021.
"Methylene Blue". 3 Little Fish Sdn Bhd. Kelana Jaya, Selangor, Malaysia. 10 September 2021.

activatedcarbon.org

"Test Methods for Activated Carbon" (PDF). European Council of Chemical Manufacturers' Federations. April 1986.

alzforum.org

"In First Phase 3 Trial, the Tau Drug LMTM Did Not Work. Period". Alzforum. 29 July 2016.

astm.org

Standard Test Method for Rapid Determination of the Methylene Blue Value for Fine Aggregate or Mineral Filler Using a Colorimeter (Report). West Conshohocken, PA: ASTM (American Society for Testing and Material) International. 7 July 2020. doi:10.1520/C1777-20. ASTM C1777. Archived from the original on 2014-02-28.

bentham-direct.org

Stawicki SP, Sims C, Sarani B, Grossman MD, Gracias VH (May 2008). "Methylene blue and vasoplegia: who, when, and how?". Mini Reviews in Medicinal Chemistry. 8 (5): 472–490. doi:10.2174/138955708784223477. PMID 18473936. Archived from the original on 2017-09-18. Retrieved 2020-04-01.

bestbets.org

Leite EG, Ronald A, Rodrigues AJ, Evora PR (December 2006). "Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?". Interactive Cardiovascular and Thoracic Surgery. 5 (6): 774–8. doi:10.1510/icvts.2006.134726. PMID 17670710. S2CID 30259038.

books.google.com

Ahmad I, Aqil F (2008). New Strategies Combating Bacterial Infection. John Wiley & Sons. p. 91. ISBN 9783527622948. Archived from the original on 2017-09-18.
Thomé SD, Petz LD (2002). "Hemolytic Anemia: Hereditary and Acquired". In Mazza J (ed.). Manual of Clinical Hematology (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. p. 102. ISBN 978-0-7817-2980-2.
Ehrlich P, Guttmann P (1891). "Über die Wirkung des Methylenblau bei Malaria" [On the effect of methylene blue on malaria]. Berliner klinische Wochhenschrift [Berlin clinical Weekly] (in German). 28: 953–956. Archived from the original on 2017-02-17.

cedd.gov.hk

Standing Committee on Concrete Technology (SCCT) (May 2013). "Construction Standard CS3:2013 – Aggregates for Concrete" (PDF). The Government of the Hong Kong Special Administrative Region.

chestnet.org

journal.chestnet.org

Mokhlesi B, Leikin JB, Murray P, Corbridge TC (March 2003). "Adult toxicology in critical care: Part II: specific poisonings". Chest. 123 (3): 897–922. doi:10.1378/chest.123.3.897. PMID 12628894. S2CID 9962335.

clinicaltrials.gov

Clinical trial number NCT00214877 for "Methylene blue for cognitive dysfunction in bipolar disorder" at ClinicalTrials.gov

csbsju.edu

employees.csbsju.edu

Jakubowski H (2016). "Chapter 8: Oxidation/Phosphorylation B: Oxidative Enzymes". Biochemistry Online.

dako.com

Kiernan JA (2010). "Chapter 19: On Chemical Reactions and Staining Mechanisms" (PDF). In Kumar GL, Kiernan JA (eds.). Special Stains and H & E. Education Guide (Second ed.). Carpinteria, California: Dako North America, Inc. p. 172. Archived from the original (PDF) on May 13, 2012. What is Giemsa's stain and how does it color blood cells, bacteria and chromosomes?

doi.org

Hanzlik PJ (4 February 1933). "Methylene Blue As Antidote for Cyanide Poisoning". JAMA. 100 (5): 357. doi:10.1001/jama.1933.02740050053028.
Hu X, Laguerre V, Packert D, Nakasone A, Moscinski L (2015). "A Simple and Efficient Method for Preparing Cell Slides and Staining without Using Cytocentrifuge and Cytoclips". International Journal of Cell Biology. 2015: 813216. doi:10.1155/2015/813216. PMC 4664808. PMID 26664363.
Wilson TM (November 1907). "On the Chemistry and Staining Properties of Certain Derivatives of the Methylene Blue Group When Combined With Eosin". The Journal of Experimental Medicine. 9 (6): 645–670. doi:10.1084/jem.9.6.645. PMC 2124692. PMID 19867116.
Wilson JG (July 1910). "Intra vitam staining with methylene blue". The Anatomical Record. 4 (7): 267–277. doi:10.1002/ar.1090040705. S2CID 86242668.
Schabadasch A (January 1930). "Untersuchungen zur Methodik der Methylenblaufärbung des vegetativen Nervensystems" [Investigations on the methodology of methylene blue staining of the autonomic nervous system.]. Zeitschrift für Zellforschung und Mikroskopische Anatomie [Journal of Cell Research and Microscopic Anatomy] (in German). 10 (2): 221–243. doi:10.1007/BF02450696. S2CID 36940327.
Kiernan JA (June 1974). "Effects of metabolic inhibitors on vital staining with methylene blue". Histochemistry. 40 (1): 51–7. doi:10.1007/BF00490273. PMID 4136702. S2CID 23158612.
Taylor GM, Avera RS, Strachan CC, Briggs CM, Medler JP, Pafford CM, Gant TB (February 2021). "Severe methemoglobinemia secondary to isobutyl nitrite toxicity: the case of the 'Gold Rush'". Oxford Medical Case Reports. 2021 (2): omaa136. doi:10.1093/omcr/omaa136. PMC 7885148. PMID 33614047.
Modarai B, Kapadia YK, Kerins M, Terris J (May 2002). "Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite". Emergency Medicine Journal. 19 (3): 270–271. doi:10.1136/emj.19.3.270. PMC 1725875. PMID 11971852.
Alici-Evcimen Y, Breitbart WS (October 2007). "Ifosfamide neuropsychiatric toxicity in patients with cancer". Psycho-Oncology. 16 (10): 956–960. doi:10.1002/pon.1161. PMID 17278152. S2CID 27433170.
Patel PN (February 2006). "Methylene blue for management of Ifosfamide-induced encephalopathy". The Annals of Pharmacotherapy. 40 (2): 299–303. doi:10.1345/aph.1G114. PMID 16391008. S2CID 21124635.
Dufour C, Grill J, Sabouraud P, Behar C, Munzer M, Motte J, et al. (February 2006). "[Ifosfamide induced encephalopathy: 15 observations]". Archives de Pédiatrie (in French). 13 (2): 140–145. doi:10.1016/j.arcped.2005.10.021. PMID 16364615.
Jang DH, Nelson LS, Hoffman RS (September 2013). "Methylene blue for distributive shock: a potential new use of an old antidote". Journal of Medical Toxicology. 9 (3): 242–249. doi:10.1007/s13181-013-0298-7. PMC 3770994. PMID 23580172.
Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD (July 2010). "Methylene blue for the treatment of septic shock". Pharmacotherapy. 30 (7): 702–715. doi:10.1592/phco.30.7.702. PMID 20575634. S2CID 759538.
Hosseinian L, Weiner M, Levin MA, Fischer GW (January 2016). "Methylene Blue: Magic Bullet for Vasoplegia?". Anesthesia and Analgesia. 122 (1): 194–201. doi:10.1213/ANE.0000000000001045. PMID 26678471. S2CID 26114442.
Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ (February 2004). "Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery". The Annals of Thoracic Surgery. 77 (2): 496–499. doi:10.1016/S0003-4975(03)01510-8. PMID 14759425.
Leite EG, Ronald A, Rodrigues AJ, Evora PR (December 2006). "Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?". Interactive Cardiovascular and Thoracic Surgery. 5 (6): 774–8. doi:10.1510/icvts.2006.134726. PMID 17670710. S2CID 30259038.
Stawicki SP, Sims C, Sarani B, Grossman MD, Gracias VH (May 2008). "Methylene blue and vasoplegia: who, when, and how?". Mini Reviews in Medicinal Chemistry. 8 (5): 472–490. doi:10.2174/138955708784223477. PMID 18473936. Archived from the original on 2017-09-18. Retrieved 2020-04-01.
Fadhlillah F, Patil S (August 2018). "Pharmacological and mechanical management of calcium channel blocker toxicity". BMJ Case Reports. 2018: bcr2018225324. doi:10.1136/bcr-2018-225324. PMC 6119390. PMID 30150339.
Saha BK, Bonnier A, Chong W (December 2020). "Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning". African Journal of Emergency Medicine. 10 (4): 284–287. doi:10.1016/j.afjem.2020.06.014. PMC 7700985. PMID 33299766.
Aggarwal N, Kupfer Y, Seneviratne C, Tessler S (January 2013). "Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose". BMJ Case Reports. 2013: bcr2012007402. doi:10.1136/bcr-2012-007402. PMC 3604019. PMID 23334490.
Pellegrini JR, Munshi R, Tiwana MS, Abraham T, Tahir H, Sayedy N, Iqbal J (October 2021). ""Feeling the Blues": A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue". Cureus. 13 (10): e19114. doi:10.7759/cureus.19114. PMC 8627593. PMID 34868762.
Ahmed S, Barnes S (2019). "Hemodynamic improvement using methylene blue after calcium channel blocker overdose". World Journal of Emergency Medicine. 10 (1): 55–58. doi:10.5847/wjem.j.1920-8642.2019.01.009. PMC 6264975. PMID 30598720.
Burkes R, Wendorf G (July 2015). "A multifaceted approach to calcium channel blocker overdose: a case report and literature review". Clinical Case Reports. 3 (7): 566–569. doi:10.1002/ccr3.300. PMC 4527798. PMID 26273444.
Chudow M, Ferguson K (April 2018). "A Case of Severe, Refractory Hypotension After Amlodipine Overdose". Cardiovascular Toxicology. 18 (2): 192–197. doi:10.1007/s12012-017-9419-x. PMID 28688059. S2CID 3713149.
Jang DH, Nelson LS, Hoffman RS (December 2011). "Methylene blue in the treatment of refractory shock from an amlodipine overdose". Annals of Emergency Medicine. 58 (6): 565–567. doi:10.1016/j.annemergmed.2011.02.025. PMID 21546119.
Laes JR, Williams DM, Cole JB (December 2015). "Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report". Journal of Medical Toxicology. 11 (4): 460–463. doi:10.1007/s13181-015-0500-1. PMC 4675606. PMID 26310944.
Mokhlesi B, Leikin JB, Murray P, Corbridge TC (March 2003). "Adult toxicology in critical care: Part II: specific poisonings". Chest. 123 (3): 897–922. doi:10.1378/chest.123.3.897. PMID 12628894. S2CID 9962335.
Harvey JW, Keitt AS (May 1983). "Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia". British Journal of Haematology. 54 (1): 29–41. doi:10.1111/j.1365-2141.1983.tb02064.x. PMID 6849836. S2CID 19304915.
Ramsay RR, Dunford C, Gillman PK (November 2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". British Journal of Pharmacology. 152 (6): 946–951. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Gillman PK (October 2006). "Methylene blue implicated in potentially fatal serotonin toxicity". Anaesthesia. 61 (10): 1013–1014. doi:10.1111/j.1365-2044.2006.04808.x. PMID 16978328. S2CID 45063314.
Rosen PJ, Johnson C, McGehee WG, Beutler E (July 1971). "Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency". Annals of Internal Medicine. 75 (1): 83–86. doi:10.7326/0003-4819-75-1-83. PMID 5091568.
Berneth H (2012). "Azine Dyes". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a03_213.pub3. ISBN 978-3527306732.
Maleki A, Nematollahi D (December 2009). "An efficient electrochemical method for the synthesis of methylene blue". Electrochemistry Communications. 11 (12): 2261–2264. doi:10.1016/j.elecom.2009.09.040.
Cenens J, Schoonheydt RA (1988). "Visible spectroscopy of methylene blue on hectorite, laponite B, and barasym in aqueous suspension". Clays and Clay Minerals. 36 (3): 214–224. Bibcode:1988CCM....36..214C. doi:10.1346/ccmn.1988.0360302. S2CID 3851037.
Cook AG, Tolliver RM, Williams JE (February 1994). "The Blue Bottle experiment revisited: How Blue? How Sweet?". Journal of Chemical Education. 71 (2): 160. Bibcode:1994JChEd..71..160C. doi:10.1021/ed071p160.
Anderson L, Wittkopp SM, Painter CJ, Liegel JJ, Schreiner R, Bell JA, Shakhashiri BZ (9 October 2012). "What is happening when the Blue Bottle bleaches: An Investigation of the methylene blue-catalyzed air oxidation of glucose". Journal of Chemical Education. 89 (11): 1425–1431. Bibcode:2012JChEd..89.1425A. doi:10.1021/ed200511d.
Rajchakit U, Limpanuparb T (9 August 2016). "Rapid Blue Bottle experiment: Autoxidation of benzoin catalyzed by redox indicators". Journal of Chemical Education. 93 (8): 1490–1494. Bibcode:2016JChEd..93.1490R. doi:10.1021/acs.jchemed.6b00018.
Harvey EN (March 1919). "The relation between the oxygen concentration and rate of reduction of methylene blue by milk". The Journal of General Physiology. 1 (4): 415–419. doi:10.1085/jgp.1.4.415. PMC 2140316. PMID 19871757.
Siegel Lewis M (1965-04-01). "A direct microdetermination for sulfide". Analytical Biochemistry. 11 (1): 126–132. doi:10.1016/0003-2697(65)90051-5. ISSN 0003-2697. PMID 14328633.
Thornton H (May 1930). "Studies on Oxidation-Reduction in Milk: The Methylene Blue Reduction Test". Journal of Dairy Science. 13 (3). Elsevier Inc.: 221–245. doi:10.3168/jds.S0022-0302(30)93520-5.
Standard Test Method for Rapid Determination of the Methylene Blue Value for Fine Aggregate or Mineral Filler Using a Colorimeter (Report). West Conshohocken, PA: ASTM (American Society for Testing and Material) International. 7 July 2020. doi:10.1520/C1777-20. ASTM C1777. Archived from the original on 2014-02-28.
Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, et al. (2009). "Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial". PLOS ONE. 4 (5): e5318. Bibcode:2009PLoSO...4.5318C. doi:10.1371/journal.pone.0005318. PMC 2673582. PMID 19415120.
Brooks MM (January 1933). "Methylene Blue As Antidote for Cyanide and Carbon Monoxide Poisoning". JAMA. 100: 59. doi:10.1001/jama.1933.02740010061028.
Schirmer RH, Coulibaly B, Stich A, Scheiwein M, Merkle H, Eubel J, et al. (2003). "Methylene blue as an antimalarial agent". Redox Report. 8 (5): 272–275. doi:10.1179/135100003225002899. PMID 14962363. S2CID 24345784.
Adams V, Marley J, McCarroll C (November 2007). "Prilocaine induced methaemoglobinaemia in a medically compromised patient. Was this an inevitable consequence of the dose administered?". British Dental Journal. 203 (10): 585–587. doi:10.1038/bdj.2007.1045. PMID 18037845.
Linz AJ, Greenham RK, Fallon LF (May 2006). "Methemoglobinemia: an industrial outbreak among rubber molding workers". Journal of Occupational and Environmental Medicine. 48 (5): 523–528. doi:10.1097/01.jom.0000201815.32098.99. PMID 16688009. S2CID 29264161.
Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, et al. (October 2006). "Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine". Malaria Journal. 5: 84. doi:10.1186/1475-2875-5-84. PMC 1617109. PMID 17026773.
Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, et al. (January 2017). "Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study". The British Journal of Psychiatry. 210 (1): 54–60. doi:10.1192/bjp.bp.115.173930. PMID 27284082.
Tardivo JP, Del Giglio A, Paschoal LH, Baptista MS (August 2006). "New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma". Photomedicine and Laser Surgery. 24 (4): 528–531. doi:10.1089/pho.2006.24.528. PMID 16942436.
Papin JF, Floyd RA, Dittmer DP (November 2005). "Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo". Antiviral Research. 68 (2): 84–87. doi:10.1016/j.antiviral.2005.07.001. PMID 16118025.
Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, Street C, Wilson M (February 2009). "In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent". BMC Microbiology. 9: 27. doi:10.1186/1471-2180-9-27. PMC 2642833. PMID 19193212.
Floyd RA, Schneider JE, Dittmer DP (March 2004). "Methylene blue photoinactivation of RNA viruses". Antiviral Research. 61 (3): 141–151. doi:10.1016/j.antiviral.2003.11.004. PMID 15168794.

dx.doi.org

Siegel Lewis M (1965-04-01). "A direct microdetermination for sulfide". Analytical Biochemistry. 11 (1): 126–132. doi:10.1016/0003-2697(65)90051-5. ISSN 0003-2697. PMID 14328633.

drugs.com

"Methylene Blue". The American Society of Health-System Pharmacists. Archived from the original on 10 May 2017. Retrieved 8 January 2017.
"Prosed/DS: Indications, Side Effects, Warnings". Drugs.com. Retrieved 2024-04-20.

elsevier.com

linkinghub.elsevier.com

Maleki A, Nematollahi D (December 2009). "An efficient electrochemical method for the synthesis of methylene blue". Electrochemistry Communications. 11 (12): 2261–2264. doi:10.1016/j.elecom.2009.09.040.

europa.eu

ema.europa.eu

"Lumeblue EPAR". European Medicines Agency. 19 June 2020. Retrieved 4 March 2023.

ec.europa.eu

"Lumeblue Product information". Union Register of medicinal products. Retrieved 3 March 2023.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

harvard.edu

ui.adsabs.harvard.edu

Brooks MM (1936). "Methylene blue as an antidote for cyanide and carbon monoxide poisoning". The Scientific Monthly. 43 (6): 585–586. Bibcode:1936SciMo..43..585M. JSTOR 16280.
Cenens J, Schoonheydt RA (1988). "Visible spectroscopy of methylene blue on hectorite, laponite B, and barasym in aqueous suspension". Clays and Clay Minerals. 36 (3): 214–224. Bibcode:1988CCM....36..214C. doi:10.1346/ccmn.1988.0360302. S2CID 3851037.
Cook AG, Tolliver RM, Williams JE (February 1994). "The Blue Bottle experiment revisited: How Blue? How Sweet?". Journal of Chemical Education. 71 (2): 160. Bibcode:1994JChEd..71..160C. doi:10.1021/ed071p160.
Anderson L, Wittkopp SM, Painter CJ, Liegel JJ, Schreiner R, Bell JA, Shakhashiri BZ (9 October 2012). "What is happening when the Blue Bottle bleaches: An Investigation of the methylene blue-catalyzed air oxidation of glucose". Journal of Chemical Education. 89 (11): 1425–1431. Bibcode:2012JChEd..89.1425A. doi:10.1021/ed200511d.
Rajchakit U, Limpanuparb T (9 August 2016). "Rapid Blue Bottle experiment: Autoxidation of benzoin catalyzed by redox indicators". Journal of Chemical Education. 93 (8): 1490–1494. Bibcode:2016JChEd..93.1490R. doi:10.1021/acs.jchemed.6b00018.
Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, et al. (2009). "Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial". PLOS ONE. 4 (5): e5318. Bibcode:2009PLoSO...4.5318C. doi:10.1371/journal.pone.0005318. PMC 2673582. PMID 19415120.

jstor.org

Brooks MM (1936). "Methylene blue as an antidote for cyanide and carbon monoxide poisoning". The Scientific Monthly. 43 (6): 585–586. Bibcode:1936SciMo..43..585M. JSTOR 16280.

medpagetoday.com

Fiore K (27 July 2016). "Tau Drug Flops in Study". MedPage Today, LLC. Archived from the original on 1 August 2016.

merck.de

photometry.merck.de

"Analytik und Probenvorbereitung". Darmstadt, Germany: Merck KGaA. Archived from the original on 2007-03-15.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hu X, Laguerre V, Packert D, Nakasone A, Moscinski L (2015). "A Simple and Efficient Method for Preparing Cell Slides and Staining without Using Cytocentrifuge and Cytoclips". International Journal of Cell Biology. 2015: 813216. doi:10.1155/2015/813216. PMC 4664808. PMID 26664363.
Wilson TM (November 1907). "On the Chemistry and Staining Properties of Certain Derivatives of the Methylene Blue Group When Combined With Eosin". The Journal of Experimental Medicine. 9 (6): 645–670. doi:10.1084/jem.9.6.645. PMC 2124692. PMID 19867116.
Kiernan JA (June 1974). "Effects of metabolic inhibitors on vital staining with methylene blue". Histochemistry. 40 (1): 51–7. doi:10.1007/BF00490273. PMID 4136702. S2CID 23158612.
Taylor GM, Avera RS, Strachan CC, Briggs CM, Medler JP, Pafford CM, Gant TB (February 2021). "Severe methemoglobinemia secondary to isobutyl nitrite toxicity: the case of the 'Gold Rush'". Oxford Medical Case Reports. 2021 (2): omaa136. doi:10.1093/omcr/omaa136. PMC 7885148. PMID 33614047.
Modarai B, Kapadia YK, Kerins M, Terris J (May 2002). "Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite". Emergency Medicine Journal. 19 (3): 270–271. doi:10.1136/emj.19.3.270. PMC 1725875. PMID 11971852.
Alici-Evcimen Y, Breitbart WS (October 2007). "Ifosfamide neuropsychiatric toxicity in patients with cancer". Psycho-Oncology. 16 (10): 956–960. doi:10.1002/pon.1161. PMID 17278152. S2CID 27433170.
Patel PN (February 2006). "Methylene blue for management of Ifosfamide-induced encephalopathy". The Annals of Pharmacotherapy. 40 (2): 299–303. doi:10.1345/aph.1G114. PMID 16391008. S2CID 21124635.
Dufour C, Grill J, Sabouraud P, Behar C, Munzer M, Motte J, et al. (February 2006). "[Ifosfamide induced encephalopathy: 15 observations]". Archives de Pédiatrie (in French). 13 (2): 140–145. doi:10.1016/j.arcped.2005.10.021. PMID 16364615.
Aeschlimann C, Cerny T, Küpfer A (December 1996). "Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue". Drug Metabolism and Disposition. 24 (12): 1336–1339. PMID 8971139.
Jang DH, Nelson LS, Hoffman RS (September 2013). "Methylene blue for distributive shock: a potential new use of an old antidote". Journal of Medical Toxicology. 9 (3): 242–249. doi:10.1007/s13181-013-0298-7. PMC 3770994. PMID 23580172.
Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD (July 2010). "Methylene blue for the treatment of septic shock". Pharmacotherapy. 30 (7): 702–715. doi:10.1592/phco.30.7.702. PMID 20575634. S2CID 759538.
Hosseinian L, Weiner M, Levin MA, Fischer GW (January 2016). "Methylene Blue: Magic Bullet for Vasoplegia?". Anesthesia and Analgesia. 122 (1): 194–201. doi:10.1213/ANE.0000000000001045. PMID 26678471. S2CID 26114442.
Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ (February 2004). "Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery". The Annals of Thoracic Surgery. 77 (2): 496–499. doi:10.1016/S0003-4975(03)01510-8. PMID 14759425.
Leite EG, Ronald A, Rodrigues AJ, Evora PR (December 2006). "Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?". Interactive Cardiovascular and Thoracic Surgery. 5 (6): 774–8. doi:10.1510/icvts.2006.134726. PMID 17670710. S2CID 30259038.
Stawicki SP, Sims C, Sarani B, Grossman MD, Gracias VH (May 2008). "Methylene blue and vasoplegia: who, when, and how?". Mini Reviews in Medicinal Chemistry. 8 (5): 472–490. doi:10.2174/138955708784223477. PMID 18473936. Archived from the original on 2017-09-18. Retrieved 2020-04-01.
Fadhlillah F, Patil S (August 2018). "Pharmacological and mechanical management of calcium channel blocker toxicity". BMJ Case Reports. 2018: bcr2018225324. doi:10.1136/bcr-2018-225324. PMC 6119390. PMID 30150339.
Saha BK, Bonnier A, Chong W (December 2020). "Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning". African Journal of Emergency Medicine. 10 (4): 284–287. doi:10.1016/j.afjem.2020.06.014. PMC 7700985. PMID 33299766.
Aggarwal N, Kupfer Y, Seneviratne C, Tessler S (January 2013). "Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose". BMJ Case Reports. 2013: bcr2012007402. doi:10.1136/bcr-2012-007402. PMC 3604019. PMID 23334490.
Pellegrini JR, Munshi R, Tiwana MS, Abraham T, Tahir H, Sayedy N, Iqbal J (October 2021). ""Feeling the Blues": A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue". Cureus. 13 (10): e19114. doi:10.7759/cureus.19114. PMC 8627593. PMID 34868762.
Ahmed S, Barnes S (2019). "Hemodynamic improvement using methylene blue after calcium channel blocker overdose". World Journal of Emergency Medicine. 10 (1): 55–58. doi:10.5847/wjem.j.1920-8642.2019.01.009. PMC 6264975. PMID 30598720.
Burkes R, Wendorf G (July 2015). "A multifaceted approach to calcium channel blocker overdose: a case report and literature review". Clinical Case Reports. 3 (7): 566–569. doi:10.1002/ccr3.300. PMC 4527798. PMID 26273444.
Chudow M, Ferguson K (April 2018). "A Case of Severe, Refractory Hypotension After Amlodipine Overdose". Cardiovascular Toxicology. 18 (2): 192–197. doi:10.1007/s12012-017-9419-x. PMID 28688059. S2CID 3713149.
Jang DH, Nelson LS, Hoffman RS (December 2011). "Methylene blue in the treatment of refractory shock from an amlodipine overdose". Annals of Emergency Medicine. 58 (6): 565–567. doi:10.1016/j.annemergmed.2011.02.025. PMID 21546119.
Laes JR, Williams DM, Cole JB (December 2015). "Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report". Journal of Medical Toxicology. 11 (4): 460–463. doi:10.1007/s13181-015-0500-1. PMC 4675606. PMID 26310944.
Mokhlesi B, Leikin JB, Murray P, Corbridge TC (March 2003). "Adult toxicology in critical care: Part II: specific poisonings". Chest. 123 (3): 897–922. doi:10.1378/chest.123.3.897. PMID 12628894. S2CID 9962335.
Harvey JW, Keitt AS (May 1983). "Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia". British Journal of Haematology. 54 (1): 29–41. doi:10.1111/j.1365-2141.1983.tb02064.x. PMID 6849836. S2CID 19304915.
Ramsay RR, Dunford C, Gillman PK (November 2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". British Journal of Pharmacology. 152 (6): 946–951. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Gillman PK (October 2006). "Methylene blue implicated in potentially fatal serotonin toxicity". Anaesthesia. 61 (10): 1013–1014. doi:10.1111/j.1365-2044.2006.04808.x. PMID 16978328. S2CID 45063314.
Rosen PJ, Johnson C, McGehee WG, Beutler E (July 1971). "Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency". Annals of Internal Medicine. 75 (1): 83–86. doi:10.7326/0003-4819-75-1-83. PMID 5091568.
Harvey EN (March 1919). "The relation between the oxygen concentration and rate of reduction of methylene blue by milk". The Journal of General Physiology. 1 (4): 415–419. doi:10.1085/jgp.1.4.415. PMC 2140316. PMID 19871757.
Siegel Lewis M (1965-04-01). "A direct microdetermination for sulfide". Analytical Biochemistry. 11 (1): 126–132. doi:10.1016/0003-2697(65)90051-5. ISSN 0003-2697. PMID 14328633.
Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, et al. (2009). "Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial". PLOS ONE. 4 (5): e5318. Bibcode:2009PLoSO...4.5318C. doi:10.1371/journal.pone.0005318. PMC 2673582. PMID 19415120.
Schirmer RH, Coulibaly B, Stich A, Scheiwein M, Merkle H, Eubel J, et al. (2003). "Methylene blue as an antimalarial agent". Redox Report. 8 (5): 272–275. doi:10.1179/135100003225002899. PMID 14962363. S2CID 24345784.
Adams V, Marley J, McCarroll C (November 2007). "Prilocaine induced methaemoglobinaemia in a medically compromised patient. Was this an inevitable consequence of the dose administered?". British Dental Journal. 203 (10): 585–587. doi:10.1038/bdj.2007.1045. PMID 18037845.
Linz AJ, Greenham RK, Fallon LF (May 2006). "Methemoglobinemia: an industrial outbreak among rubber molding workers". Journal of Occupational and Environmental Medicine. 48 (5): 523–528. doi:10.1097/01.jom.0000201815.32098.99. PMID 16688009. S2CID 29264161.
Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, et al. (October 2006). "Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine". Malaria Journal. 5: 84. doi:10.1186/1475-2875-5-84. PMC 1617109. PMID 17026773.
Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, et al. (January 2017). "Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study". The British Journal of Psychiatry. 210 (1): 54–60. doi:10.1192/bjp.bp.115.173930. PMID 27284082.
Tardivo JP, Del Giglio A, Paschoal LH, Baptista MS (August 2006). "New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma". Photomedicine and Laser Surgery. 24 (4): 528–531. doi:10.1089/pho.2006.24.528. PMID 16942436.
Papin JF, Floyd RA, Dittmer DP (November 2005). "Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo". Antiviral Research. 68 (2): 84–87. doi:10.1016/j.antiviral.2005.07.001. PMID 16118025.
Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, Street C, Wilson M (February 2009). "In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent". BMC Microbiology. 9: 27. doi:10.1186/1471-2180-9-27. PMC 2642833. PMID 19193212.
Floyd RA, Schneider JE, Dittmer DP (March 2004). "Methylene blue photoinactivation of RNA viruses". Antiviral Research. 61 (3): 141–151. doi:10.1016/j.antiviral.2003.11.004. PMID 15168794.
Wagner SJ, Skripchenko A, Robinette D, Mallory DA, Hirayama J, Cincotta L, Foley J (2000). "The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions". Developments in Biologicals. 102: 125–129. PMID 10794099.

ncbi.nlm.nih.gov

Hu X, Laguerre V, Packert D, Nakasone A, Moscinski L (2015). "A Simple and Efficient Method for Preparing Cell Slides and Staining without Using Cytocentrifuge and Cytoclips". International Journal of Cell Biology. 2015: 813216. doi:10.1155/2015/813216. PMC 4664808. PMID 26664363.
Wilson TM (November 1907). "On the Chemistry and Staining Properties of Certain Derivatives of the Methylene Blue Group When Combined With Eosin". The Journal of Experimental Medicine. 9 (6): 645–670. doi:10.1084/jem.9.6.645. PMC 2124692. PMID 19867116.
Taylor GM, Avera RS, Strachan CC, Briggs CM, Medler JP, Pafford CM, Gant TB (February 2021). "Severe methemoglobinemia secondary to isobutyl nitrite toxicity: the case of the 'Gold Rush'". Oxford Medical Case Reports. 2021 (2): omaa136. doi:10.1093/omcr/omaa136. PMC 7885148. PMID 33614047.
Modarai B, Kapadia YK, Kerins M, Terris J (May 2002). "Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite". Emergency Medicine Journal. 19 (3): 270–271. doi:10.1136/emj.19.3.270. PMC 1725875. PMID 11971852.
Jang DH, Nelson LS, Hoffman RS (September 2013). "Methylene blue for distributive shock: a potential new use of an old antidote". Journal of Medical Toxicology. 9 (3): 242–249. doi:10.1007/s13181-013-0298-7. PMC 3770994. PMID 23580172.
Fadhlillah F, Patil S (August 2018). "Pharmacological and mechanical management of calcium channel blocker toxicity". BMJ Case Reports. 2018: bcr2018225324. doi:10.1136/bcr-2018-225324. PMC 6119390. PMID 30150339.
Saha BK, Bonnier A, Chong W (December 2020). "Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning". African Journal of Emergency Medicine. 10 (4): 284–287. doi:10.1016/j.afjem.2020.06.014. PMC 7700985. PMID 33299766.
Aggarwal N, Kupfer Y, Seneviratne C, Tessler S (January 2013). "Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose". BMJ Case Reports. 2013: bcr2012007402. doi:10.1136/bcr-2012-007402. PMC 3604019. PMID 23334490.
Pellegrini JR, Munshi R, Tiwana MS, Abraham T, Tahir H, Sayedy N, Iqbal J (October 2021). ""Feeling the Blues": A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue". Cureus. 13 (10): e19114. doi:10.7759/cureus.19114. PMC 8627593. PMID 34868762.
Ahmed S, Barnes S (2019). "Hemodynamic improvement using methylene blue after calcium channel blocker overdose". World Journal of Emergency Medicine. 10 (1): 55–58. doi:10.5847/wjem.j.1920-8642.2019.01.009. PMC 6264975. PMID 30598720.
Burkes R, Wendorf G (July 2015). "A multifaceted approach to calcium channel blocker overdose: a case report and literature review". Clinical Case Reports. 3 (7): 566–569. doi:10.1002/ccr3.300. PMC 4527798. PMID 26273444.
Laes JR, Williams DM, Cole JB (December 2015). "Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report". Journal of Medical Toxicology. 11 (4): 460–463. doi:10.1007/s13181-015-0500-1. PMC 4675606. PMID 26310944.
Ramsay RR, Dunford C, Gillman PK (November 2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". British Journal of Pharmacology. 152 (6): 946–951. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Harvey EN (March 1919). "The relation between the oxygen concentration and rate of reduction of methylene blue by milk". The Journal of General Physiology. 1 (4): 415–419. doi:10.1085/jgp.1.4.415. PMC 2140316. PMID 19871757.
Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, et al. (2009). "Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial". PLOS ONE. 4 (5): e5318. Bibcode:2009PLoSO...4.5318C. doi:10.1371/journal.pone.0005318. PMC 2673582. PMID 19415120.
Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, et al. (October 2006). "Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine". Malaria Journal. 5: 84. doi:10.1186/1475-2875-5-84. PMC 1617109. PMID 17026773.
Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, Street C, Wilson M (February 2009). "In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent". BMC Microbiology. 9: 27. doi:10.1186/1471-2180-9-27. PMC 2642833. PMID 19193212.

dailymed.nlm.nih.gov

"Provayblue- methylene blue injection". DailyMed. 29 June 2022. Retrieved 4 March 2023.

pei.de

Ehrlich P (1887). "Ueber die Methylenblau Reaktion der lebenden Nerven Substanz" [About the methylene blue reaction of the living nerve substance.] (PDF). Biologisches Zentralblatt [Biological Central Journal] (in German). 6: 214–224. cited by Baker JR (1958). Principles of biological microtechnique. A study of fixation and dyeing. London: Methuen.

sciencebasedmedicine.org

Novella S (23 January 2008). "The ethics of deception in medicine". Science Based Medicine. Archived from the original on 2008-01-29. Retrieved 2008-01-24.

semanticscholar.org

api.semanticscholar.org

Wilson JG (July 1910). "Intra vitam staining with methylene blue". The Anatomical Record. 4 (7): 267–277. doi:10.1002/ar.1090040705. S2CID 86242668.
Schabadasch A (January 1930). "Untersuchungen zur Methodik der Methylenblaufärbung des vegetativen Nervensystems" [Investigations on the methodology of methylene blue staining of the autonomic nervous system.]. Zeitschrift für Zellforschung und Mikroskopische Anatomie [Journal of Cell Research and Microscopic Anatomy] (in German). 10 (2): 221–243. doi:10.1007/BF02450696. S2CID 36940327.
Kiernan JA (June 1974). "Effects of metabolic inhibitors on vital staining with methylene blue". Histochemistry. 40 (1): 51–7. doi:10.1007/BF00490273. PMID 4136702. S2CID 23158612.
Alici-Evcimen Y, Breitbart WS (October 2007). "Ifosfamide neuropsychiatric toxicity in patients with cancer". Psycho-Oncology. 16 (10): 956–960. doi:10.1002/pon.1161. PMID 17278152. S2CID 27433170.
Patel PN (February 2006). "Methylene blue for management of Ifosfamide-induced encephalopathy". The Annals of Pharmacotherapy. 40 (2): 299–303. doi:10.1345/aph.1G114. PMID 16391008. S2CID 21124635.
Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD (July 2010). "Methylene blue for the treatment of septic shock". Pharmacotherapy. 30 (7): 702–715. doi:10.1592/phco.30.7.702. PMID 20575634. S2CID 759538.
Hosseinian L, Weiner M, Levin MA, Fischer GW (January 2016). "Methylene Blue: Magic Bullet for Vasoplegia?". Anesthesia and Analgesia. 122 (1): 194–201. doi:10.1213/ANE.0000000000001045. PMID 26678471. S2CID 26114442.
Leite EG, Ronald A, Rodrigues AJ, Evora PR (December 2006). "Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?". Interactive Cardiovascular and Thoracic Surgery. 5 (6): 774–8. doi:10.1510/icvts.2006.134726. PMID 17670710. S2CID 30259038.
Chudow M, Ferguson K (April 2018). "A Case of Severe, Refractory Hypotension After Amlodipine Overdose". Cardiovascular Toxicology. 18 (2): 192–197. doi:10.1007/s12012-017-9419-x. PMID 28688059. S2CID 3713149.
Mokhlesi B, Leikin JB, Murray P, Corbridge TC (March 2003). "Adult toxicology in critical care: Part II: specific poisonings". Chest. 123 (3): 897–922. doi:10.1378/chest.123.3.897. PMID 12628894. S2CID 9962335.
Harvey JW, Keitt AS (May 1983). "Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia". British Journal of Haematology. 54 (1): 29–41. doi:10.1111/j.1365-2141.1983.tb02064.x. PMID 6849836. S2CID 19304915.
Gillman PK (October 2006). "Methylene blue implicated in potentially fatal serotonin toxicity". Anaesthesia. 61 (10): 1013–1014. doi:10.1111/j.1365-2044.2006.04808.x. PMID 16978328. S2CID 45063314.
Cenens J, Schoonheydt RA (1988). "Visible spectroscopy of methylene blue on hectorite, laponite B, and barasym in aqueous suspension". Clays and Clay Minerals. 36 (3): 214–224. Bibcode:1988CCM....36..214C. doi:10.1346/ccmn.1988.0360302. S2CID 3851037.
Schirmer RH, Coulibaly B, Stich A, Scheiwein M, Merkle H, Eubel J, et al. (2003). "Methylene blue as an antimalarial agent". Redox Report. 8 (5): 272–275. doi:10.1179/135100003225002899. PMID 14962363. S2CID 24345784.
Linz AJ, Greenham RK, Fallon LF (May 2006). "Methemoglobinemia: an industrial outbreak among rubber molding workers". Journal of Occupational and Environmental Medicine. 48 (5): 523–528. doi:10.1097/01.jom.0000201815.32098.99. PMID 16688009. S2CID 29264161.

web.archive.org

"Methylene Blue". The American Society of Health-System Pharmacists. Archived from the original on 10 May 2017. Retrieved 8 January 2017.
Ahmad I, Aqil F (2008). New Strategies Combating Bacterial Infection. John Wiley & Sons. p. 91. ISBN 9783527622948. Archived from the original on 2017-09-18.
Kiernan JA (2010). "Chapter 19: On Chemical Reactions and Staining Mechanisms" (PDF). In Kumar GL, Kiernan JA (eds.). Special Stains and H & E. Education Guide (Second ed.). Carpinteria, California: Dako North America, Inc. p. 172. Archived from the original (PDF) on May 13, 2012. What is Giemsa's stain and how does it color blood cells, bacteria and chromosomes?
Novella S (23 January 2008). "The ethics of deception in medicine". Science Based Medicine. Archived from the original on 2008-01-29. Retrieved 2008-01-24.
Stawicki SP, Sims C, Sarani B, Grossman MD, Gracias VH (May 2008). "Methylene blue and vasoplegia: who, when, and how?". Mini Reviews in Medicinal Chemistry. 8 (5): 472–490. doi:10.2174/138955708784223477. PMID 18473936. Archived from the original on 2017-09-18. Retrieved 2020-04-01.
"Analytik und Probenvorbereitung". Darmstadt, Germany: Merck KGaA. Archived from the original on 2007-03-15.
Standard Test Method for Rapid Determination of the Methylene Blue Value for Fine Aggregate or Mineral Filler Using a Colorimeter (Report). West Conshohocken, PA: ASTM (American Society for Testing and Material) International. 7 July 2020. doi:10.1520/C1777-20. ASTM C1777. Archived from the original on 2014-02-28.
Ehrlich P, Guttmann P (1891). "Über die Wirkung des Methylenblau bei Malaria" [On the effect of methylene blue on malaria]. Berliner klinische Wochhenschrift [Berlin clinical Weekly] (in German). 28: 953–956. Archived from the original on 2017-02-17.
Fiore K (27 July 2016). "Tau Drug Flops in Study". MedPage Today, LLC. Archived from the original on 1 August 2016.

wiley.com

onlinelibrary.wiley.com

Harvey JW, Keitt AS (May 1983). "Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia". British Journal of Haematology. 54 (1): 29–41. doi:10.1111/j.1365-2141.1983.tb02064.x. PMID 6849836. S2CID 19304915.

worldcat.org

Siegel Lewis M (1965-04-01). "A direct microdetermination for sulfide". Analytical Biochemistry. 11 (1): 126–132. doi:10.1016/0003-2697(65)90051-5. ISSN 0003-2697. PMID 14328633.

zenodo.org

Wilson JG (July 1910). "Intra vitam staining with methylene blue". The Anatomical Record. 4 (7): 267–277. doi:10.1002/ar.1090040705. S2CID 86242668.